Cargando…

Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study

BACKGROUND AND OBJECTIVE: Rheumatoid arthritis associated-interstitial lung disease (RA-ILD) is the most common pulmonary manifestation of rheumatoid arthritis (RA) and an important cause of mortality. In patients suffering from interstitial lung diseases (ILD) from different etiologies (including R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Denis, Anna, Henket, Monique, Ernst, Marie, Maes, Nathalie, Thys, Marie, Regnier, Céline, Malaise, Olivier, Frix, Anne-Noëlle, Gester, Fanny, Desir, Colin, Meunier, Paul, Louis, Renaud, Malaise, Michel, Guiot, Julien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748274/ https://www.ncbi.nlm.nih.gov/pubmed/36530900 http://dx.doi.org/10.3389/fmed.2022.1024298

Ejemplares similares

Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis
por: Guiot, Julien, et al.
Publicado: (2023)

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?
por: Guiot, Julien, et al.
Publicado: (2022)

The Role of Imaging in the Detection of Non-COVID-19 Pathologies during the Massive Screening of the First Pandemic Wave
por: Canivet, Perrine, et al.
Publicado: (2022)

Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction
por: Guiot, Julien, et al.
Publicado: (2021)

Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
por: Bonhomme, Olivier, et al.
Publicado: (2019)

Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity
por: Guiot, Julien, et al.
Publicado: (2022)

Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p
por: Guiot, Julien, et al.
Publicado: (2020)

Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic
por: Guiot, J., et al.
Publicado: (2020)

Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection
por: Calmes, Doriane, et al.
Publicado: (2021)

A new nucleosomic-based model to identify and diagnose SSc-ILD
por: Guiot, Julien, et al.
Publicado: (2020)

Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers
por: Jacquerie, P., et al.
Publicado: (2021)

YKL-40 as a new promising prognostic marker of severity in COVID infection
por: Schoneveld, Lauranne, et al.
Publicado: (2021)

A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome
por: Parzibut, Gilles, et al.
Publicado: (2021)

Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis
por: Guiot, Julien, et al.
Publicado: (2023)

Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
por: Guiot, Julien, et al.
Publicado: (2023)

Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial
por: De Niet, Sophie, et al.
Publicado: (2022)

Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study
por: Darcis, Gilles, et al.
Publicado: (2021)

Increased KL-6 levels in moderate to severe COVID-19 infection
por: Cambier, Maureen, et al.
Publicado: (2022)

Development and Validation of an Automated Radiomic CT Signature for Detecting COVID-19
por: Guiot, Julien, et al.
Publicado: (2020)

Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets
por: Guiot, Julien, et al.
Publicado: (2019)

Reproducibility of pulmonary function tests in patients with systemic sclerosis
por: Jacquerie, P., et al.
Publicado: (2023)

Exosomal Long Non-Coding RNAs in Lung Diseases
por: Poulet, Christophe, et al.
Publicado: (2020)

AI-Based Chest CT Analysis for Rapid COVID-19 Diagnosis and Prognosis: A Practical Tool to Flag High-Risk Patients and Lower Healthcare Costs
por: Esposito, Giovanni, et al.
Publicado: (2022)

Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
por: Radermecker, Coraline, et al.
Publicado: (2020)

Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries
por: Hilberg, Ole, et al.
Publicado: (2022)

Blood Biomarkers in Idiopathic Pulmonary Fibrosis
por: Guiot, Julien, et al.
Publicado: (2017)

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Management of Fibrosing Interstitial Lung Diseases
por: Maher, Toby M., et al.
Publicado: (2019)

Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study
por: Sebastiani, Marco, et al.
Publicado: (2023)

Radiomics in Lung Diseases Imaging: State-of-the-Art for Clinicians
por: Frix, Anne-Noëlle, et al.
Publicado: (2021)

Dissociation between 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission
por: Rinkin, Charline, et al.
Publicado: (2021)

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)
por: Nasser, Mouhamad, et al.
Publicado: (2021)

Diagnosis of Idiopathic Pulmonary Fibrosis in High-Resolution Computed Tomography Scans Using a Combination of Handcrafted Radiomics and Deep Learning
por: Refaee, Turkey, et al.
Publicado: (2022)

The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)

Management of patients with fibrosing interstitial lung diseases
por: Morrow, Lee E, et al.
Publicado: (2021)

Fibrosing interstitial lung diseases: knowns and unknowns
por: Cottin, Vincent, et al.
Publicado: (2019)

High detection rate of osteoporosis with screening of a general hospitalized population: a 6-year study in 6406 patients in a university hospital setting
por: Malaise, Olivier, et al.
Publicado: (2020)

Exposure–safety analyses of nintedanib in patients with chronic fibrosing interstitial lung disease
por: Schmid, Ulrike, et al.
Publicado: (2021)

Biomarkers of Fibroproliferative Healing in Fibrosing Idiopathic Interstitial Pneumonias
por: Vasakova, Martina, et al.
Publicado: (2012)

The natural history of progressive fibrosing interstitial lung diseases
por: Kolb, Martin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k9siv367j3r3ua2mdg50js7r6b